Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

Objective To examine clinical effectiveness and safety of apixaban 2.5 mg, dabigatran 110 mg, and rivaroxaban 15 mg compared with warfarin among patients with atrial fibrillation who had not previously taken an oral anticoagulant. Design Propensity weighted (inverse probability of treatment weighted...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Peter Brønnum, Skjøth, Flemming, Søgaard, Mette, Kjældgaard, Jette Nordstrøm, Lip, Gregory Y H, Larsen, Torben Bjerregaard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421446/
https://www.ncbi.nlm.nih.gov/pubmed/28188243
http://dx.doi.org/10.1136/bmj.j510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421446/
https://www.ncbi.nlm.nih.gov/pubmed/28188243
http://dx.doi.org/10.1136/bmj.j510

Ejemplares similares